Dr. Aparna Kalyan
Claim this profileNorthwestern University
Studies Bile Duct Cancer
Studies Pancreatic Cancer
22 reported clinical trials
40 drugs studied
About Aparna Kalyan
Education:
- Earned an MD from Flinders University of South Australia in 2005.
- Completed Residency at The MetroHealth System/Case Western Reserve University in 2011.
- Completed Fellowships at UPMC Medical Education (2014) and McGaw Medical Center of Northwestern University (2015).
Experience:
- Associate Professor at the Feinberg School of Medicine, Northwestern University.
- Focuses on treating a variety of cancers, including anal, colon, esophageal, gastrointestinal, liver, pancreatic, rectal, small bowel, and stomach cancers.
- Board-certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine.
Area of expertise
1Bile Duct Cancer
Stage IV
Stage III
RAF positive
2Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Aparna Kalyan is currently running
Chemotherapy vs Chemoradiotherapy
for Rectal Cancer
This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limited surgery? If radiation therapy is not given, is quality of life better?
Recruiting2 awards Phase 3
Nivolumab + Standard Treatment
for Stomach and Esophageal Cancer
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
Recruiting1 award Phase 2 & 320 criteria
More about Aparna Kalyan
Clinical Trial Related3 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Aparna Kalyan has experience with
- Nivolumab
- Oxaliplatin
- Fluorouracil
- Cabozantinib
- Ipilimumab
- Nab-paclitaxel
Breakdown of trials Aparna Kalyan has run
Bile Duct Cancer
Pancreatic Cancer
Gallbladder Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aparna Kalyan specialize in?
Aparna Kalyan focuses on Bile Duct Cancer and Pancreatic Cancer. In particular, much of their work with Bile Duct Cancer has involved Stage IV patients, or patients who are Stage III.
Is Aparna Kalyan currently recruiting for clinical trials?
Yes, Aparna Kalyan is currently recruiting for 5 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Aparna Kalyan has studied deeply?
Yes, Aparna Kalyan has studied treatments such as Nivolumab, Oxaliplatin, Fluorouracil.
What is the best way to schedule an appointment with Aparna Kalyan?
Apply for one of the trials that Aparna Kalyan is conducting.
What is the office address of Aparna Kalyan?
The office of Aparna Kalyan is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.